Vivus and Sanofi Chimie have entered into a commercial supply agreement to manufacture and supply the API for avanafil. The pact is on an exclusive basis in the U.S. and other territories and on a semi-exclusive basis in the EU and Latin America. Avanafil is a treatment for erectile dysfunction sold under the name Stendra. “Sanofi was the logical choice for avanafil API manufacturing,” said Theodore Broman, vice president, chemistry manufacturing and control, Vivus. “Their wor...